MOUNJARO
Drug
Lilly USA, LLC
Total Payments
$35.6M
Transactions
551,105
Doctors
96,591
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $12.6M | 231,525 | 66,089 |
| 2023 | $13.2M | 219,343 | 61,105 |
| 2022 | $9.8M | 100,237 | 44,458 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.0M | 22,132 | 67.3% |
| Food and Beverage | $10.6M | 521,083 | 29.9% |
| Travel and Lodging | $580,699 | 7,439 | 1.6% |
| Consulting Fee | $410,938 | 155 | 1.2% |
| Education | $7,584 | 296 | 0.0% |
Top Doctors Receiving Payments for MOUNJARO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Family Medicine | Bethel Park, PA | $240,071 | 550 |
| , M.D | Endocrinology, Diabetes & Metabolism | Opelika, AL | $239,475 | 352 |
| , APRN | Nurse Practitioner | Topeka, KS | $239,019 | 686 |
| , M.D | Endocrinology, Diabetes & Metabolism | San Antonio, TX | $235,330 | 449 |
| , MD | Endocrinology, Diabetes & Metabolism | Amherst, NY | $234,266 | 320 |
| , MD | Endocrinology, Diabetes & Metabolism | Camp Springs, MD | $231,561 | 291 |
| , MD | Internal Medicine | Wichita, KS | $229,064 | 289 |
| , MD | Endocrinology, Diabetes & Metabolism | Wilmington, NC | $224,111 | 414 |
| , M.D | Endocrinology, Diabetes & Metabolism | Philadelphia, PA | $220,903 | 222 |
| , M.D | Endocrinology, Diabetes & Metabolism | Plano, TX | $218,729 | 480 |
| , D.O | Internal Medicine | Falls Church, VA | $218,589 | 402 |
| , DO | Endocrinology, Diabetes & Metabolism | Westerville, OH | $217,203 | 390 |
| , M.D | Endocrinology, Diabetes & Metabolism | Springfield, MO | $216,766 | 290 |
| , MD | Endocrinology, Diabetes & Metabolism | Port Charlotte, FL | $212,019 | 352 |
| , APN | Family | Hermitage, TN | $211,914 | 583 |
| , M.D | Endocrinology, Diabetes & Metabolism | Chicago, IL | $211,288 | 353 |
| , M.D | Family Medicine | Winnsboro, SC | $211,005 | 329 |
| , MD | Endocrinology, Diabetes & Metabolism | Chesterfield, MO | $208,908 | 412 |
| , MD | Endocrinology, Diabetes & Metabolism | Lubbock, TX | $208,304 | 445 |
| , M.D | Internal Medicine | Weslaco, TX | $202,062 | 341 |
| , MD | Internal Medicine | Richmond, VA | $201,369 | 310 |
| , MD | Endocrinology, Diabetes & Metabolism | N New Hyde Pk, NY | $201,161 | 243 |
| , MD | Internal Medicine | Nashville, TN | $201,033 | 292 |
| , DO, MD, MS | Hospitalist | Williamsville, NY | $199,702 | 353 |
| , M.D | Endocrinology, Diabetes & Metabolism | Asheville, NC | $199,040 | 310 |
Ad
Manufacturing Companies
- Lilly USA, LLC $35.4M
- Eli Lilly and Company $215,772
- Eli Lilly Export S.A. Puerto Rico Branch $12,136
Product Information
- Type Drug
- Total Payments $35.6M
- Total Doctors 96,591
- Transactions 551,105
About MOUNJARO
MOUNJARO is a drug associated with $35.6M in payments to 96,591 healthcare providers, recorded across 551,105 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2022 to 2024. In 2024, $12.6M was paid across 231,525 transactions to 66,089 doctors.
The most common payment nature for MOUNJARO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24.0M, 67.3% of total).